Literature DB >> 8442402

Myelography, CT, and MRI of the spinal canal in patients with myelopathy: a prospective study.

P Arlien-Søborg1, L Kjaer, J Praestholm.   

Abstract

A prospective study including myelography, CT, and MRI was performed on 36 patients with clinical signs of myelopathy. Evoked potentials and spinal fluid examinations were also carried out. Based on our findings, the patients could be classified as suffering from cryptogenic myelopathy (n = 12), multiple sclerosis (n = 6), spinal stenosis (n = 6), or miscellaneous myelopathies (n = 12). The diameter of the spinal cord was normal in the 2 first groups of patients and of same magnitude evaluated by myelography and CT, while MRI constantly gave higher figures. In only four of the patients important new information was added by CT and MRI (syringomyelia, myelitis, lipomatosis) compared with myelography, although a more precise visualization was often provided. Further diagnostic progress in patients with myelopathy of undetermined etiology may be obtained by including supplementary MRI of the brain disclosing multiple sclerosis in several cases.

Entities:  

Mesh:

Year:  1993        PMID: 8442402     DOI: 10.1111/j.1600-0404.1993.tb04084.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Comparison of spinal anatomy between 3-Tesla MRI and CT-myelography under healthy and pathological conditions.

Authors:  Astrid Ellen Grams; Jens Gempt; Annette Förschler
Journal:  Surg Radiol Anat       Date:  2009-12-06       Impact factor: 1.246

2.  Augmented reality and artificial intelligence-assisted surgical navigation: Technique and cadaveric feasibility study.

Authors:  Kris B Siemionow; Karina M Katchko; Paul Lewicki; Cristian J Luciano
Journal:  J Craniovertebr Junction Spine       Date:  2020-06-05

3.  Acute myelopathy of unknown aetiology: a clinical, neurophysiological and MRI study of short- and long-term prognostic factors.

Authors:  V Martinelli; G Comi; M Rovaris; M Filippi; B Colombo; T Locatelli; A Campi; M Rodegher; N Canal
Journal:  J Neurol       Date:  1995-08       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.